Loading...

Isavuconazole Prophylaxis in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients

BACKGROUND: Isavuconazole (ISA) is an attractive candidate for primary mold-active prophylaxis in high-risk patients with hematologic malignancies or hematopoietic cell transplant (HCT) recipients. However, data supporting the use of ISA for primary prophylaxis in these patients are lacking. METHODS...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Infect Dis
Main Authors: Fontana, Lauren, Perlin, David S, Zhao, Yanan, Noble, Brie N, Lewis, James S, Strasfeld, Lynne, Hakki, Morgan
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7931837/
https://ncbi.nlm.nih.gov/pubmed/30958538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz282
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!